 
					Meghan Rosen is a senior writer who reports on the life sciences for Science News. She earned a Ph.D. in biochemistry and molecular biology with an emphasis in biotechnology from the University of California, Davis. Her dissertation work involved studying mutated proteins in liver and kidney cancer. She later graduated from the science communication program at UC Santa Cruz. Prior to joining Science News in 2022, she was a media relations manager at the Howard Hughes Medical Institute. Her work has appeared in Wired, Science, and The Washington Post, among other outlets. Once for McSweeney’s, she wrote about her kids’ habit of handing her trash, a story that still makes her (and them) laugh.
 
Trustworthy journalism comes at a price.
Scientists and journalists share a core belief in questioning, observing and verifying to reach the truth. Science News reports on crucial research and discovery across science disciplines. We need your financial support to make it happen – every contribution makes a difference.
All Stories by Meghan Rosen
- 			 Health & Medicine Health & MedicineAI could transform health care, but will it live up to the hype?AI has the potential to make health care more effective, equitable and humane. Whether the tech delivers on these promises remains to be seen. 
- 			 Health & Medicine Health & MedicineShort bursts of physical activity cut women’s risk of heart attackEven just a few minutes of vigorous movement per day lowers the risk of serious cardiovascular problems, like heart attack and heart failure, in women. 
- 			 Health & Medicine Health & MedicineDogs team up with AI to sniff out cancerScientists paired Labrador retrievers with an AI model in a new screening test for breast, lung, colorectal or prostate cancer. 
- 			 Health & Medicine Health & MedicineThe benefits of Ozempic and its kin may extend far beyond weight lossStudies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss. 
- 			 Health & Medicine Health & MedicineHow the weight loss drug tirzepatide is also helping heart failure patientsData continue to show that tirzepatide, called Mounjaro for type 2 diabetes and Zepbound for weight loss, is safe and effective, but side effects remain. 
- 			 Health & Medicine Health & MedicineRefurbished heart pacemakers work like new“Old” pacemakers may still work for years, so doctors are refurbishing used devices and donating them to patients in low- and middle-income countries. 
- 			 Health & Medicine Health & Medicine‘The Power of Prions’ explores misfolded proteins’ role in brain diseasesMichel Brahic’s new book spotlights prions’ role in diseases such as Alzheimer’s and Parkinson’s. 
- 			 Life LifeBackyard explorers discovered 15 new examples of glowing lifeNew finds in the Finding Fluorescence site include a Japanese beetle with a glowing blue mouth and a mushroom that gleamed bright red under its cap. 
- 			 Health & Medicine Health & MedicineA viral gene drive could offer a new approach to fighting herpesA new gene drive can copy and paste itself into the genomes of herpes simplex viruses in mice. The end goal is a version that disables the virus in humans. 
- 			 Chemistry ChemistryWork on protein structure and design wins the 2024 chemistry NobelDavid Baker figured out how to build entirely new proteins. Demis Hassabis and John Jumper developed an AI tool to predict protein structures. 
- 			 Health & Medicine Health & MedicineA hurricane’s aftermath may spur up to 11,000 deathsHurricanes like Helene may indirectly cause deaths for years. Stress, pollution and a loss of infrastructure could all contribute to tropical cyclone fatalities. 
- 			 Health & Medicine Health & MedicineSemaglutide may reduce opioid overdoses, a new study suggestsA study of people with type 2 diabetes and opioid use disorder suggests that the key ingredient in Ozempic and Wegovy shows promise against addiction.